Functional consequences of Rett syndrome mutations on human MeCP2

AUTOR(ES)

Yusufzai, Timur M.

FONTE

Oxford University Press

RESUMO

The neurodevelopmental disorder known as Rett syndrome has recently been linked to the methyl-CpG-binding transcriptional repressor, MeCP2. In this report we examine the consequences of these mutations on the function of MeCP2. The ability to bind specifically to methylated DNA and the transcription repression capabilities are tested, as well as the stability of proteins in vivo. We find that all missense mutations (R106W, R133C, F155S, T158M) within the methyl-binding domain impair selectivity for methylated DNA, and that all nonsense mutations (L138X, R168X, E235X, R255X, R270X, V288X, R294X) that truncate all or some of the transcriptional repression domain (TRD) affect the ability to repress transcription and have decreased levels of stability in vivo. Two missense mutations, one in the TRD (R306C) and one in the C-terminus (E397K), had no noticeable effects on MeCP2 function. Together, these results provide evidence of how Rett syndrome mutations can affect distinct functions of MeCP2 and give insight into these mutations that may contribute to the disease.

Documentos Relacionados

• Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice
• Rett Syndrome and MeCP2: Linking Epigenetics and Neuronal Function
• MECP2 Mutations in Sporadic Cases of Rett Syndrome Are Almost Exclusively of Paternal Origin
• Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations
• Methylation-dependent silencing at the H19 imprinting control region by MeCP2